I beg to differ! If it is not a sequencing mistake—and it looks clean—one of these BA.3.2 has something completely novel in SARS-CoV-2 evolution: an FCS-adjacent deletion!
One of the two QT repeats appears to have been deleted. I've never seen anything like this before.
Work by @TheMenacheryLab looked at a similar, more extensive, deletion. They deleted both QT repeats plus the next AA (∆QTQTN). In Vero cells (monkey kidney cells), it produced extra-large plaques & outcompeted WT virus—similar to furin cleavage site (FCS)-deletion mutants. 2/12
But in human lung cancer (Calu3) cells, the ∆QTQTN-mutant replication was dramatically reduced (2.5 orders of magnitude), and in infected hamsters disease was much milder. 3/12
Oddly, despite reduced illness and demonstrably reduced cell entry in vitro, viral replication was apparently increased in hamsters in the nose and throat (as measured by viral RNA titers), while lung replication was unchanged.
Hard to make sense of. 4/12
What's certain is that the ∆QTQTN deletion reduces (furin) S1/S2 cleavage. The smaller ∆QT in this BA.3.2 (assuming it is real, as it appears to be), likely has a similar effect.
Would love to hear @StuartTurville's take on this.
5/12
Importantly, there's never been a variant with a deletion like this. Though there were a few early reports of FCS-adjacent deletions, I'm skeptical they were real. All were from the same lab, led by a fraudulent scientist (Didier Raoult) who's since had 48 papers retracted. 6/12
Also, while the FCS lab experiments are immensely valuable, they took place on an ancestral spike background. BA.3.2 has (relative to WT) N679R & P681H. P681H has been shown many times over to increase spike cleavage, and N679R almost certainly also has that effect. 7/12
Furthermore, BA.3.2 has huge deletions in the spike NTD (S:1-306). The resulting shorter NTD loops (also in SARS-1) have been shown by @EnyaQing to dramatically increase spike cleavage and infectivity (and instability). 8/12
Old 🧵 on this topic:
Regions around the FCS have been completely reconfigured in BA.3.2. On top of Omicron's H655Y (which increases time spent in intermediate fusion configurations), it has K529N, E554D, A575S, E583D, H625R, N641K, V642G, and E654K upstream & A688D + S704L downstream of the FCS. 9/12
And further upstream, in S2, BA.3.2 has two extraordinarily rare & meaningful mutations—S:K795T & the 2-nuc S:A852K.
So the effect of this new FCS-adjacent deletion on infectivity & tropism may be completely different than on a WT spike background. 10/12
Finally, this deletion, which likely decreases S1/S2 cleavage, may be part of a larger trend in SARS-CoV-2 evolution. Recently there seems to be real selection pressure for mutations that temper S1/S2 cleavage. It's not clear why (incr stability?) 11/12
In any case, while the precise consequences of all this aren't known, one thing is clear: BA.3.2 is very different from past variants, none of which could tolerate a deletion like this. What it means going forward is anyone's guess. 12/12
• • •
Missing some Tweet in this thread? You can try to
force a refresh
There's a new BA.3.2.2 from South Africa today. For the most part, there's been little substantial change in BA.3.2 over the past few months—mostly synonymous mutations & very little happening in spike.
But this new one has 3 spike mutations & looks quite interesting. 1/7
For those not following closely, here's a 🧵 I made about BA.3.2 (not yet designated at the time) that I made some months ago, when it first burst upon the scene. 2/7
Attenuation of the SARS-2 furin-cleavage site (FCS) continues apace. It's beginning to look as if some form of FCS-weakening mutation might well become fixed in the near future. Collectively, they are at ~12% globally—a totally unprecedented level—& rising quickly. 1/4
In South America, this may have already happened. Recent sequences are scarce, but they nearly all have some sort of FCS-weakening mutation, mostly S:S680P in XFG.3.4.1, but with several others (S680F, S680Y, R683Q, R683W) contributing as well. 2/4
The enigmatic anti-correlation between S:∆S31 & FCS ablaters—clear since summer 2024—is strong as ever. Here are the recent CovSpectrum stats for T22N & ∆S31 among all seqs & seqs w/FCS weakeners.
How exactly a 1-AA deletion in a distant region affects the FCS is unknown. 3/4
There's been some speculation about why, despite persistent immune activation, germinal center activity, & overall elevated Ab levels, LC patients here had very low anti-spike Ab titers. I want to highlight one interesting speculative hypothesis & offer another possibility. 1/10
The ever-fertile mind of @Nucleocapsoid proffers the possibility that exosomes could be responsible for viral spread in some tissue reservoirs. I don't know much about this topic and so don't have much to say at the moment, but I'm trying to l learn. 2/
I'll offer one other possibility: the deep lung environment (or some other tissue reservoir) favors either an extreme RBD-up or extreme RBD-down conformation.
Background: The receptor-binding domain (RBD) of the spike trimer can be up or down. It has to be up to bind ACE2... 3/
A fascinating new preprint w/one very unexpected finding suggests, I believe, that a large proportion of Long Covid may be due to chronic infection in a particular bodily niche, which could be crucial for finding effective LC treatments. It requires some explaining. 🧵 1/33
First, a brief summary of the relevant parts of the preprint. They examined 30 people (from NIH RECOVER cohort) for 6 months after they had Covid, taking detailed blood immunological markers at 3 time points. 20 had Long Covid (PASC), 10 did not (CONV). 2/ biorxiv.org/content/10.110…
The PASC group showed signs of persistent, pro-inflammatory immune activation over the 6-month time period that suggested ongoing mucosal immune responses, including elevated levels of mucosa-associated invariant T cells (MAIT). 3/
Wow, BA.3.2 hits its 4th continent with a new sequence from Western Australia.
Reminder: BA.3.2 is a saltation variant resulting from a ~3-year chronic infection. It is very different from and more immune-evasive than all other current variants. 1/4
It was collected July 15, & is most closely related to the recent S African seqs from May & June.
It has an NSP5 mutation known to be beneficial (ORF1a:K3353R) & 2 new NSP12 mutations, which is unusual. Its 9 synonymous mutations indicate it has been circulating somewhere. 2/4
Seems clear now that BA.3.2 is not going away anytime soon. Its overall impact so far has been negligible, but at first BA.2.86's was as well. Once it got S:L455S (becoming JN.1) the dam burst & it set off a new wave in the global North. The question now is.... 3/4
BA.3.2 update: another sequence from the Netherlands, June 18 collection.
It belongs on the same branch as the GBW travel seq (tree gets confused by ORF7-8 deletion). Also, there are 3 artifactual muts in the GBW sequence (as usual), so the branch is shorter than it looks.
Bottom line, in my view: BA.3.2 has spread internationally & is likely growing, but very slowly. If nothing changes, its advantage vs circulating lineages, which seem stuck in an evolutionary rut, will likely gradually grow as immunity to dominant variants solidifies... 2/9
So far, this seems like a slow-motion version of what we saw with BA.2.86, which spread internationally & grew very slowly for months. But then it got S:L455S & exploded, wiping out all competitors. Will something similar happen with BA.3.2? I think there's a good chance... 3/9